HRID1633855

反应详情

EQUATION

反应方程式

REACTANTS

反应物

结构：COC(=O)C[C@H]1Nc2ccc(C(=O)O)cc2CN(C)C1=O

HCID11220043

未命名化合物

HCID11401058

N-METHYL-1-(1-METHYL-1H-INDOL-2-YL)-METHANAMINE

C11H14N2

HCID23505581

未命名化合物

HCID53726847

未命名化合物

PRODUCTS

生成物

结构：CN(Cc1cc2ccccc2n1Cc1ccc(O)cc1)C(=O)c1ccc2c(c1)CN(C)C(=O)[C@@H](CO)N2

HCID54280820

未命名化合物

收率 92.2%

PROCEDURE

实验过程

According to the procedure of Example 1(a), except substituting 1-(4-hydroxybenzyl)-2-(methylaminomethyl)indole (0.40 g, 1.50 mmole) for the 1-methyl-2-(methylaminomethyl)indole, and substituting (2R)-2-(hydroxymethyl)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carboxylic acid (0.34 g, 1.37 mmole) for the (2R)-2-[(carbomethoxy)methyl]-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine-7-carboxylic acid, the title compound (0.63 g, 92%) was prepared as an off-white solid: MS (ES) m/e 499 (M+H)+.

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-2f76afedb7314fc88d04e6486142e4bf
来源数据集: uspto-grants-2003_01
DOI: 10.6084/m9.figshare.5104873.v1
专利: US06503903B1
来源说明: uspto-grants-2003_01

反应 SMILES

[OH:1][C:2]1[CH:20]=[CH:19][C:5]([CH2:6][N:7]2[C:15]3[C:10](=[CH:11][CH:12]=[CH:13][CH:14]=3)[CH:9]=[C:8]2[CH2:16][NH:17][CH3:18])=[CH:4][CH:3]=1.CN1C2C(=CC=CC=2)C=C1CNC.[OH:34][CH2:35][C@@H:36]1[C:42](=[O:43])[N:41]([CH3:44])[CH2:40][C:39]2[CH:45]=[C:46]([C:49](O)=[O:50])[CH:47]=[CH:48][C:38]=2[NH:37]1.C(C[C@@H]1C(=O)N(C)CC2C=C(C(O)=O)C=CC=2N1)(OC)=O>>[CH3:18][N:17]([CH2:16][C:8]1[N:7]([CH2:6][C:5]2[CH:4]=[CH:3][C:2]([OH:1])=[CH:20][CH:19]=2)[C:15]2[C:10]([CH:9]=1)=[CH:11][CH:12]=[CH:13][CH:14]=2)[C:49]([C:46]1[CH:47]=[CH:48][C:38]2[NH:37][C@H:36]([CH2:35][OH:34])[C:42](=[O:43])[N:41]([CH3:44])[CH2:40][C:39]=2[CH:45]=1)=[O:50]